High Creatinine, Low eGFR? Why Bodybuilders Need Cystatin C

You get your bloodwork back. Your creatinine is flagged high. Your eGFR reads 52. Your doctor mentions "stage 3 kidney disease" and you feel your stomach drop.

But here's the thing: if you're a muscular athlete, especially one using performance-enhancing drugs, that number is almost certainly wrong. Not slightly off. Potentially coin-flip wrong.

This article explains why creatinine-based kidney tests fail for bodybuilders, what you should be testing instead, and exactly how to monitor your kidneys if you use trenbolone, oral AAS, or even just TRT.

Why Creatinine Lies in Muscular Athletes

Creatinine is a waste product of creatine phosphate metabolism in skeletal muscle. More muscle means more creatinine in your blood. This is not disease. It is basic physiology.

The correlation between fat-free mass and serum creatinine is strong: r = 0.734 in controlled studies (Baxmann et al., 2008). Physically active subjects show significantly higher creatinine than sedentary controls (1.04 vs 0.95 mg/dL), even with perfectly healthy kidneys. For a bodybuilder carrying 100+ kg of lean mass, the gap is far wider.

But muscle mass is only one of three factors stacking against you.

Creatine Supplementation

If you supplement creatine (and most bodybuilders do), oral creatine is partially hydrolyzed to creatinine in the gut before absorption. One documented case showed serum creatinine spiking to 227 umol/L (eGFR 28) on creatine ethyl ester, improving to 104 umol/L (eGFR 70) within two weeks of stopping. No underlying kidney pathology was found (Williamson & New, 2014).

High-Protein Diet

A single cooked beef meal can raise serum creatinine by up to 98.5%, peaking about 2 hours post-meal and resolving after a 12-hour fast (Nair et al., 2014). If you're eating 300-500g of red meat daily, you're carrying a sustained dietary creatinine load that standard reference ranges never accounted for.

The eGFR Problem

Here's where it gets dangerous. eGFR is calculated from creatinine. If your creatinine is artificially high, your eGFR is artificially low.

In the highest muscle mass quartile, the standard CKD-EPI equation has a specificity of just 47.4% for detecting true kidney impairment (Nankivell et al., 2020). That is worse than a coin flip. eGFR drops by roughly 5.9 mL/min for every 10 kg of additional lean mass, entirely from the creatinine confound.

So a jacked 110 kg bodybuilder can receive an eGFR of 45 and be told he has stage 3 CKD when his kidneys are completely fine.

Cystatin C: The Marker Your Doctor Hasn't Ordered

Cystatin C is a small protein produced by all nucleated cells in your body at a near-constant rate. It is freely filtered by the kidneys and fully reabsorbed in the tubules. Its serum concentration depends almost entirely on how well your kidneys filter it.

The critical difference: cystatin C has zero correlation with fat-free mass (r = 0) (Baxmann et al., 2008). It does not care how much muscle you carry. It does not care what you ate for dinner. It does not care if you take creatine.

A 2024 study of 227 men on testosterone with documented muscle hypertrophy confirmed this: cystatin C showed no meaningful correlation with BMI across any body composition subgroup (R-squared = 0.0001 in normal-BMI athletes) (Ashouri et al., 2024).

What the Guidelines Say

The 2024 KDIGO (Kidney Disease: Improving Global Outcomes) guidelines now give a Grade 1B recommendation to use the combined creatinine + cystatin C eGFR equation when cystatin C is available, specifically in patients where body habitus may confound creatinine. That includes athletes with high muscle mass.

The combined equation (eGFRcr-cys) achieves over 90% accuracy, outperforming either single-marker equation (Inker et al., 2021). It is now the guideline-endorsed gold standard.

The Normal Range

Normal serum cystatin C: 0.53 to 0.95 mg/L. Values above this suggest reduced kidney function independent of muscle mass.

The Proof It Works for AAS Users

In a direct comparison of bodybuilders using AAS versus supplement-only controls, creatinine-based eGFR showed no significant difference between groups (119.67 vs 122.08 mL/min, p = 0.426). Creatinine completely missed the signal. But cystatin C-based eGFR revealed a statistically significant difference (120.67 vs 127.33 mL/min, p = 0.039) (Ozkurt et al., 2023).

Creatinine said "everything's fine." Cystatin C said "there's early damage here." The AAS users also had significantly elevated urine albumin-to-creatinine ratios, confirming subclinical glomerular stress.

The Steroid Caveat: When Cystatin C Isn't Perfect Either

Cystatin C has its own confounders. Before you treat it as infallible, you need to know where it breaks down.

Corticosteroids Raise Cystatin C Directly

Prednisone treatment raised serum cystatin C from 1.24 to 1.61 mg/L in heart failure patients with no change in actual kidney function (Zhai et al., 2016). The mechanism is direct: glucocorticoid receptor activation upregulates cystatin C gene transcription across all tissues (Zhu et al., 2019).

This means if you're using dexamethasone, prednisone, or other corticosteroids (sometimes used pre-contest or for inflammation), your cystatin C will read falsely high.

Do Anabolic Steroids Affect Cystatin C?

This is the open question. The Ozkurt 2023 study noted that raw serum cystatin C values were nearly identical between AAS users and controls (0.91 vs 0.88 mg/L, p = 0.263), with the significant difference appearing only at the calculated eGFR level. The study authors explicitly state that it remains unresolved whether lower eGFRcys in AAS users reflects genuine kidney damage or a direct AAS-mediated effect on cystatin C production.

The honest answer: we don't know yet. This is exactly why the combined equation (using both creatinine and cystatin C) is the recommended approach. It partially cancels out the confounders from each marker.

Thyroid Status Matters

A meta-analysis of 11 studies found that hyperthyroidism significantly raises cystatin C, while hypothyroidism lowers it (Xin et al., 2021). If you're running T3 for a cut, your cystatin C may read higher than your actual kidney function. If your thyroid is suppressed (which can happen on certain AAS protocols), cystatin C may mask real impairment.

How Steroids Damage the Kidneys

Understanding the mechanisms matters because it tells you what to watch for and which compounds carry the highest risk.

FSGS: The Irreversible Endpoint

Focal segmental glomerulosclerosis (FSGS) is the signature kidney disease of long-term AAS abuse. In a landmark case series of 10 bodybuilders with kidney symptoms, 9 out of 10 had FSGS on biopsy. Mean proteinuria was 10.1 g/day and mean serum creatinine was 3.0 mg/dL. Seven showed 40% or greater tubular atrophy and interstitial fibrosis, indicating structural damage (Herlitz et al., 2010).

The good news: among 7 patients who stopped AAS and started RAAS blockade (ACE inhibitors or ARBs), all showed stabilisation or improvement. The bad news: one patient who resumed AAS progressed to end-stage renal disease.

The eGFR Hit

A cross-sectional study of 137 weightlifters (57 current AAS users, 28 former, 52 non-users) found current users had an average eGFR of 88.5 mL/min versus 104.8 in non-users: a mean difference of -17 mL/min (Hudson et al., 2020). Former users sat in between at 97.4 mL/min, and recovery did not significantly improve with longer abstinence (p = 0.32). This suggests prolonged use causes structural changes that do not fully reverse.

The Mechanisms

AAS damages the kidneys through multiple simultaneous pathways (Davani-Davari et al., 2019):

• RAAS potentiation: AAS activates the renin-angiotensin-aldosterone system, raising intraglomerular pressure
• Endothelin production: causes renal arteriolar vasoconstriction
• Oxidative stress: reactive oxygen species damage tubular cells
• Pro-inflammatory cytokines: TNF-alpha, IL-1b, and IL-6 drive chronic inflammation
• Caspase-dependent apoptosis: direct cell death in tubular and glomerular tissue

Which Compounds Are Most Nephrotoxic?

Not all PEDs carry equal kidney risk:

Highest risk: Trenbolone is the most frequently cited nephrotoxic PED in case literature. Its high androgenic potency, strong RAAS activation, and oxidative stress profile make it the compound most associated with kidney injury. It has no legitimate human pharmaceutical formulation, so dosing is entirely uncontrolled.

High risk: Oral 17-alpha-alkylated steroids like Anadrol cause direct tubular nephrotoxicity. One documented case showed oxymetholone-induced acute renal failure via rhabdomyolysis (Tarashande Foumani & Elyasi, 2018). Oral AAS also cause cholestatic liver injury, which can lead to secondary bile acid nephropathy.

Moderate risk: High-dose injectable AAS stacks at supraphysiologic doses. The AKI cases documented by Almukhtar et al. (2015) all involved injectable anabolic steroids combined with high-protein diets and creatine, with creatinine reaching 2.6-3.8 mg/dL. All four patients recovered within 4 weeks of cessation.

Independent risk: Growth hormone causes glomerular hyperfiltration through IGF-1-mediated vasodilation. GH excess produces direct podocyte injury and glomerulosclerosis (Haffner et al., 2021). If you stack AAS + GH + a high-protein diet, you're hitting the kidney from three independent directions.

The Stacking Problem

Bodybuilders rarely use single compounds in isolation. Most kidney injury cases involve the simultaneous combination of AAS (RAAS activation), NSAIDs for joint pain (prostaglandin protection removed), high-protein diets (hyperfiltration stress), and dehydration from training. Each factor is manageable alone; together, they create the documented AKI cases. Cutting any one stressor meaningfully reduces the overall risk.

The Complete Kidney Panel for PED Users

The standard metabolic panel is not enough if you use any performance-enhancing drugs. Request this full panel:

How to Interpret the eGFR Gap

The gap between eGFRcr and eGFRcys is the most clinically useful signal for this population:

• eGFRcr and eGFRcys are similar: Kidney function is likely as reported. The creatinine confound is minimal.
• eGFRcr is higher than eGFRcys by more than 15 mL/min: Genuine kidney impairment is likely. Creatinine is being inflated by muscle mass, masking a real GFR decline that cystatin C detects.
• eGFRcys is higher than eGFRcr: Creatinine is likely confounded by muscle mass, creatine, or diet. Your kidneys are probably healthier than creatinine suggests.

ACR Staging

The current KDIGO classification uses three albuminuria categories:

• A1 (normal): ACR below 3 mg/mmol (below 30 mg/g)
• A2 (moderately increased): ACR 3 to 30 mg/mmol (30-300 mg/g)
• A3 (severely increased): ACR above 30 mg/mmol (above 300 mg/g)

An A2 result on two separate tests is clinically significant, even if eGFR appears normal. Always collect your urine sample on a rest day (exercise causes transient proteinuria) and use an early-morning spot sample for the most accurate reading.

How Often to Test

• Before your first cycle or TRT: Baseline panel including cystatin C and ACR
• Mid-cycle (8-10 weeks): Repeat full panel
• Post-cycle or PCT: Repeat to assess recovery
• Blast-and-cruise / ongoing TRT: Every 6 months minimum
• On nephrotoxic compounds (trenbolone, high-dose orals): Increase to every 8-12 weeks

Early Warning Signs You Shouldn't Ignore

Kidney damage from AAS is often clinically silent until it's advanced. The Herlitz FSGS patients had proteinuria averaging 10.1 g/day before most were diagnosed. By that point, structural damage was extensive.

Watch for these signals:

• Persistent ACR elevation (A2 category on repeat testing): The earliest lab signal, often appearing before any eGFR decline
• Widening gap between eGFRcr and eGFRcys: If this gap is growing over time, genuine kidney function is declining while creatinine masks it
• Foamy urine: Albumin acts as a surfactant; persistent foam in the toilet bowl is a visible sign of proteinuria and should prompt an immediate ACR test
• Rising blood pressure: AAS raises BP through RAAS activation; elevated BP accelerates glomerulosclerosis; glomerulosclerosis further raises BP. This feedback loop is the dominant driver of AAS-related kidney disease progression
• Peripheral edema: Swelling in the ankles and lower legs can indicate fluid retention from impaired kidney function

The Hudson 2020 data showed that even former AAS users still had eGFR 7.4 mL/min lower than non-users, and recovery did not improve with longer abstinence duration. This is why catching damage early matters: the window for reversibility closes.

Protecting Your Kidneys on Cycle

Blood Pressure Is Everything

Blood pressure control is the single highest-leverage intervention for kidney protection. Target below 130/80 mmHg on cycle. AAS-induced hypertension via RAAS activation is the primary driver of glomerulosclerosis, and controlling it directly interrupts the damage pathway.

If you need medication, ACE inhibitors or ARBs are preferred over other antihypertensives in this context. They reduce BP and provide direct renoprotection by lowering intraglomerular pressure. The Herlitz FSGS patients who improved all received RAAS blockade in addition to stopping AAS.

Compound Selection

If you have any existing kidney concerns, the highest-risk compounds to avoid are trenbolone (all esters) and high-dose oral 17-alpha-alkylated AAS like Anadrol and Dianabol. Injectable testosterone at moderate doses carries substantially lower nephrotoxic risk than these compounds.

Drop the NSAIDs

NSAID use is extremely common among bodybuilders for joint pain. Ibuprofen at over 1,200 mg/day carries an odds ratio of 1.89 for acute kidney injury, rising to 2.32 at 2,400 mg/day (Tidmas et al., 2022). Combined with dehydration during training and AAS-driven RAAS activation, NSAIDs remove the compensatory vasodilation that protects kidney perfusion. Paracetamol (acetaminophen) is a safer alternative for pain management on cycle.

Stay Hydrated

Adequate hydration (3-4L per day minimum on cycle) maintains renal blood flow and reduces the concentration of nephrotoxic metabolites. Dehydration compounds every other kidney stressor.

High-Protein Diets: Context Matters

Protein intake above 1.5 g/kg/day increases intraglomerular pressure through hyperfiltration (de Lorenzo et al., 2024). In a healthy kidney, this is compensated. In a kidney already stressed by AAS, the additional haemodynamic load is additive. This does not mean you should slash protein intake, but it does mean monitoring is non-negotiable if you're running nephrotoxic compounds on a high-protein diet.

Monitor Relentlessly

Regular bloodwork is the foundation of harm reduction. Kidney damage from AAS is partially reversible if caught early. In the Herlitz series, all 7 patients who stopped AAS and started RAAS blockade saw stabilisation or improvement. The one who continued using progressed to dialysis.

If your ACR starts trending upward, your eGFR gap is widening, or your CRP is chronically elevated, those are signals to act, not ignore.

Key Takeaways

• Creatinine-based eGFR is unreliable for muscular athletes. High muscle mass, creatine supplementation, and high-protein diets all inflate creatinine, making your eGFR look worse than reality. In the highest muscle mass quartile, standard eGFR has just 47.4% specificity.
• Cystatin C is the superior kidney marker for bodybuilders. It has zero correlation with muscle mass and is now recommended by KDIGO 2024 guidelines for dual-marker testing.
• Neither marker is perfect alone. Corticosteroids and possibly AAS can raise cystatin C independently of kidney function. The combined eGFRcr-cys equation is the gold standard.
• AAS causes real kidney damage. FSGS was found in 9 of 10 symptomatic long-term users. Current users show an average eGFR 17 mL/min lower than non-users, and recovery after cessation is incomplete.
• Trenbolone and oral AAS carry the highest nephrotoxic risk. If you use these compounds, increase monitoring frequency to every 8-12 weeks.
• Blood pressure control is the #1 kidney protection strategy. Target below 130/80 mmHg. ACE inhibitors or ARBs are preferred.
• Urine ACR is your earliest warning. It detects glomerular damage before eGFR changes. Test on a rest day, confirm abnormal results on repeat.
• Early detection saves kidneys. Damage caught early is often reversible with compound cessation and RAAS blockade. Damage caught late may not be.

Related Reading

• The Complete Guide to Bloodwork for Bodybuilders for the full overview of every marker you should track
• Liver Enzymes on Steroids for organ protection on the hepatic side
• GLP-1 Bloodwork Guide if you're using semaglutide or tirzepatide (dehydration risk compounds kidney stress)
• TRT, Haemoglobin, and Haematocrit for the full TRT monitoring picture

---

References

1. Baxmann, A. C., Ahmed, M. S., Marques, N. C., Menon, V. B., Pereira, A. B., Kirsztajn, G. M., & Heilberg, I. P. (2008). Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clinical Journal of the American Society of Nephrology, 3(2), 348-354. PubMed

2. Williamson, L., & New, D. (2014). How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology. BMJ Case Reports, 2014, bcr2014204754. PubMed

3. Nair, S., O'Brien, S. V., Hayden, K., Pandya, B., Lisboa, P. J. G., Hardy, K. J., & Wilding, J. P. H. (2014). Effect of a cooked meat meal on serum creatinine and estimated glomerular filtration rate in diabetes-related kidney disease. Diabetes Care, 37(2), 483-487. PubMed

4. Nankivell, B. J., Nankivell, L. F. J., Elder, G. J., & Gruenewald, S. M. (2020). How unmeasured muscle mass affects estimated GFR and diagnostic inaccuracy. EClinicalMedicine, 29-30, 100662. PubMed

5. Ozkurt, S., Ozakin, E., Gungor, H., & Yalcin, A. U. (2023). Assessment of renal function of bodybuilders using anabolic androgenic steroids and diet supplements. Cureus, 15(8), e43058. PubMed

6. Ashouri, R., Lertkitcharoenpon, A., Maidaa, M., Brunner, B., Velazquez, O., Lipshultz, L., & Campbell, K. (2024). Creatinine and cystatin C: A measure of renal function in men with testosterone-induced muscle hypertrophy. American Journal of Men's Health, 18(5), 15579883241286654. PubMed

7. Inker, L. A., Eneanya, N. D., Coresh, J., Tighiouart, H., Wang, D., Sang, Y., ... & Levey, A. S. (2021). New creatinine- and cystatin C-based equations to estimate GFR without race. New England Journal of Medicine, 385(19), 1737-1749. PubMed

8. Zhai, J. L., Ge, N., Zhen, Y., Zhao, Q., & Liu, C. (2016). Corticosteroids significantly increase serum cystatin C concentration without affecting renal function in symptomatic heart failure. Clinical Laboratory, 62(1-2), 203-207. PubMed

9. Zhu, X. R., Ge, N., Wang, Y., Zhai, J. L., & Liu, C. (2019). Corticosteroids significantly increase cystatin C levels in the plasma by promoting cystatin C production in rats. Renal Failure, 41(1), 698-703. PubMed

10. Xin, C., Xie, J., Fan, H., Sun, X., & Shi, B. (2021). Association between serum cystatin C and thyroid diseases: A systematic review and meta-analysis. Frontiers in Endocrinology, 12, 766516. PubMed

11. Herlitz, L. C., Markowitz, G. S., Farris, A. B., Schwimmer, J. A., Stokes, M. B., Kunis, C., Colvin, R. B., & D'Agati, V. D. (2010). Development of focal segmental glomerulosclerosis after anabolic steroid abuse. Journal of the American Society of Nephrology, 21(1), 163-172. PubMed

12. Hudson, J. I., Kanayama, G., Pope, H. G., Jr., Muse, S., Kaufman, M. J., Baggish, A., & Waikar, S. S. (2020). Glomerular filtration rate and supraphysiologic-dose anabolic-androgenic steroid use: A cross-sectional cohort study. American Journal of Kidney Diseases, 76(1), 152-155. PubMed

13. Davani-Davari, D., Karimzadeh, I., & Khalili, H. (2019). The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: A systematic review. BMC Nephrology, 20, 198. PubMed

14. Tarashande Foumani, A., & Elyasi, F. (2018). Oxymetholone-induced acute renal failure: A case report. Caspian Journal of Internal Medicine, 9(4), 410-412. PubMed

15. Almukhtar, S. E., Abbas, A. A., Muhealdeen, D. N., & Hughson, M. D. (2015). Acute kidney injury associated with androgenic steroids and nutritional supplements in bodybuilders. Clinical Kidney Journal, 8(4), 415-419. PubMed

16. Haffner, D., Grund, A., & Leifheit-Nestler, M. (2021). Renal effects of growth hormone in health and in kidney disease. Pediatric Nephrology, 36(8), 2511-2530. PubMed

17. Tidmas, V., Brazier, J., Hawkins, J., Forbes, S. C., Bottoms, L., & Farrington, K. (2022). Nutritional and non-nutritional strategies in bodybuilding: Impact on kidney function. International Journal of Environmental Research and Public Health, 19(7), 4288. PubMed

18. de Lorenzo, A., Bomback, A. S., & Mihic, N. (2024). High protein diets and glomerular hyperfiltration in athletes and bodybuilders: Is chronic kidney disease the real finish line? Sports Medicine, 54(10), 2481-2495. PubMed